Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX6WFU
|
||||
| Drug Name |
N-[3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl]-N-methylamine
|
||||
| Synonyms |
CHEMBL227644
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C18H22N2
|
||||
| Canonical SMILES |
[11CH3]NCCCN1c2ccccc2CCc3ccccc13
|
||||
| InChI |
InChI=1S/C18H22N2/c1-19-13-6-14-20-17-9-4-2-7-15(17)11-12-16-8-3-5-10-18(16)20/h2-5,7-10,19H,6,11-14H2,1H3/i1-1
|
||||
| InChIKey |
HCYAFALTSJYZDH-BJUDXGSMSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1B receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.